PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
171.25%
Net income growth of 171.25% while Healthcare median is zero at 0.00%. Walter Schloss would note a slight edge that could grow if sustained.
5.29%
D&A growth of 5.29% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
219.33%
Deferred tax growth of 219.33% while Healthcare median is zero at 0.00%. Walter Schloss would see a difference that might matter for future cash flow if significant.
-34.35%
SBC declines yoy while Healthcare median is 0.00%. Seth Klarman would see a near-term advantage in less dilution unless new hires are needed.
-36.33%
Working capital is shrinking yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if sales remain robust.
46.66%
AR growth of 46.66% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or more relaxed credit if revenue is not matching it.
-39.66%
Inventory shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see a working capital edge if sales hold up.
-43.57%
AP shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see better immediate cost coverage if top-line remains intact.
25.06%
Growth of 25.06% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or unusual one-time factors behind the difference.
-138.57%
Other non-cash items dropping yoy while Healthcare median is 2.28%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
-28.58%
Negative CFO growth while Healthcare median is 0.00%. Seth Klarman would suspect a firm-specific operational weakness if peers maintain growth.
-39.28%
CapEx declines yoy while Healthcare median is 0.00%. Seth Klarman would note a short-term FCF advantage if revenue is stable.
241.53%
Acquisition growth of 241.53% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or partial deals fueling that difference.
99.97%
Purchases growth of 99.97% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or new strategic positions driving the difference.
-69.91%
We liquidate less yoy while Healthcare median is 0.00%. Seth Klarman would see a firm-specific hold strategy unless missed gains exist.
-99.96%
We reduce “other investing” yoy while Healthcare median is 0.00%. Seth Klarman would see a potential advantage in preserving cash if top-line growth is not harmed.
-755.57%
Reduced investing yoy while Healthcare median is 0.00%. Seth Klarman sees potential advantage in near-term liquidity if revenue remains stable.
7.03%
Debt repayment growth of 7.03% while Healthcare median is zero at 0.00%. Walter Schloss wonders if expansions or a shift in capital structure drive that difference.
591.99%
Issuance growth of 591.99% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or acquisitions financed by new shares.
No Data
No Data available this quarter, please select a different quarter.